Annual EBITDA
$9.14B$8.04B-46.79%
Summary
- Current Value
- As of today, ABBV annual EBITDA is $9.14B, down -46.79% on
- Historical Performance
- ABBV annual EBITDA is down -61.82% over the past 3 years, and down -25.27% over the past 5 years
- All-Time High Comparison
- ABBV annual EBITDA is currently -62.20% below its historical high of $24.17B set on
- 3-Year Low Comparison
- ABBV annual EBITDA is at its 3-year low
- Sector Comparison
- ABBV annual EBITDA is higher than 98.73% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $9.14B | -46.8% | -61.8% | -25.3% | +57.5% | |
| Quarterly EBITDA | $6.67B | +10.2% | -16.7% | +14.8% | +444.2% | |
| TTM EBITDA | $27.37B | +8.1% | -8.8% | +47.9% | +2132.5% | |
| Price | $229.31 | +27.8% | +41.9% | +114.0% | – | |
| PE Ratio | 173.02 | +130.6% | +610.0% | +362.3% | – | |
| Annual Revenue | $56.33B | +3.7% | +0.2% | +69.3% | +296.3% | |
| Annual EPS | $2.39 | -12.1% | -63.0% | -54.8% | -18.5% | |
| Annual EBIT | $9.14B | +7.8% | -40.7% | -10.5% | +79.1% | |
| Annual Net Income | $4.25B | -12.1% | -63.0% | -45.9% | -8.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $24.17B | N/A | -62.2% |
| 5Y | $24.17B | -62.2% | |
| All | $24.17B | -62.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $9.14B | at low | |
| 5Y | $9.14B | at low | |
| All | $3.58B | +154.9% |
EBITDA History
FAQ
What is the current annual EBITDA of ABBV?
As of today, ABBV annual EBITDA is $9.14B
What is 1-year change in ABBV annual EBITDA?
ABBV annual EBITDA is down -46.79% year-over-year
What is 3-year change in ABBV annual EBITDA?
ABBV annual EBITDA is down -61.82% over the past 3 years
How far is ABBV annual EBITDA from its all-time high?
ABBV annual EBITDA is currently -62.20% below its historical high of $24.17B set on December 31, 2022
How does ABBV annual EBITDA rank versus sector peers?
ABBV annual EBITDA is higher than 98.73% of companies in Healthcare sector
When is ABBV next annual earnings release?
The next annual earnings release for ABBV is on
Quarterly EBITDA
$6.67B$1.22B-15.41%
Summary
- Current Value
- As of today, ABBV quarterly EBITDA is $6.67B, down -15.41% on
- Historical Performance
- ABBV quarterly EBITDA is up +10.21% year-over-year, and down -16.72% over the past 3 years
- All-Time High Comparison
- ABBV quarterly EBITDA is currently -19.08% below its historical high of $8.24B set on
- 3-Year Low Comparison
- ABBV quarterly EBITDA is +31.76% above its 3-year low of $5.06B reached on
- Sector Comparison
- ABBV quarterly EBITDA is higher than 99.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $6.67B | -15.4% | +10.2% | -16.7% | +14.8% | |
| Annual EBITDA | $9.14B | – | -46.8% | -61.8% | -25.3% | |
| TTM EBITDA | $27.37B | +2.3% | +8.1% | -8.8% | +47.9% | |
| Price | $229.31 | -3.1% | +27.8% | +41.9% | +114.0% | |
| PE Ratio | 173.02 | -3.1% | +130.6% | +610.0% | +362.3% | |
| Quarterly Revenue | $15.78B | +2.3% | +9.1% | +6.5% | +22.3% | |
| Quarterly EPS | $0.10 | -81.0% | -88.7% | -95.5% | -92.3% | |
| Quarterly EBIT | $4.89B | -15.7% | +23.4% | -16.1% | +38.4% | |
| Quarterly Net Income | $178.00M | -80.9% | -88.5% | -95.5% | -92.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.89B | -15.4% | |
| 3Y | $8.24B | N/A | -19.1% |
| 5Y | $8.24B | -19.1% | |
| All | $8.24B | -19.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.04B | +10.5% | |
| 3Y | $5.06B | +31.8% | |
| 5Y | $5.06B | +31.8% | |
| All | $381.85M | +1647.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ABBV?
As of today, ABBV quarterly EBITDA is $6.67B
What is ABBV quarterly EBITDA most recent change?
ABBV quarterly EBITDA was down -15.41% on September 30, 2025
What is 1-year change in ABBV quarterly EBITDA?
ABBV quarterly EBITDA is up +10.21% year-over-year
How far is ABBV quarterly EBITDA from its all-time high?
ABBV quarterly EBITDA is currently -19.08% below its historical high of $8.24B set on December 31, 2022
How does ABBV quarterly EBITDA rank versus sector peers?
ABBV quarterly EBITDA is higher than 99.64% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
TTM EBITDA
$27.37B$618.00M+2.31%
Summary
- Current Value
- As of today, ABBV TTM EBITDA is $27.37B, up +2.31% on
- Historical Performance
- ABBV TTM EBITDA is up +8.07% year-over-year, and down -8.75% over the past 3 years
- All-Time High Comparison
- ABBV TTM EBITDA is currently -13.86% below its historical high of $31.77B set on
- 3-Year Low Comparison
- ABBV TTM EBITDA is +9.61% above its 3-year low of $24.97B reached on
- Sector Comparison
- ABBV TTM EBITDA is higher than 99.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $27.37B | +2.3% | +8.1% | -8.8% | +47.9% | |
| Annual EBITDA | $9.14B | – | -46.8% | -61.8% | -25.3% | |
| Quarterly EBITDA | $6.67B | -15.4% | +10.2% | -16.7% | +14.8% | |
| Price | $229.31 | -3.1% | +27.8% | +41.9% | +114.0% | |
| PE Ratio | 173.02 | -3.1% | +130.6% | +610.0% | +362.3% | |
| TTM Revenue | $59.64B | +2.3% | +7.4% | +3.2% | +46.7% | |
| TTM EPS | $1.33 | -36.9% | -53.8% | -82.3% | -72.0% | |
| TTM EBIT | $19.37B | +5.0% | +13.9% | -11.1% | +42.3% | |
| TTM Net Income | $2.36B | -36.9% | -53.8% | -82.3% | -67.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $27.37B | at high | |
| 3Y | $31.77B | -13.9% | |
| 5Y | $31.77B | -13.9% | |
| All | $31.77B | -13.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.97B | N/A | +9.6% |
| 3Y | $24.97B | +9.6% | |
| 5Y | $21.10B | N/A | +29.7% |
| All | $1.23B | +2132.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ABBV?
As of today, ABBV TTM EBITDA is $27.37B
What is ABBV TTM EBITDA most recent change?
ABBV TTM EBITDA was up +2.31% on September 30, 2025
What is 1-year change in ABBV TTM EBITDA?
ABBV TTM EBITDA is up +8.07% year-over-year
How far is ABBV TTM EBITDA from its all-time high?
ABBV TTM EBITDA is currently -13.86% below its historical high of $31.77B set on March 31, 2023
How does ABBV TTM EBITDA rank versus sector peers?
ABBV TTM EBITDA is higher than 99.64% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
EBITDA Formula
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv